do glp 1 work for everyone Weight loss drugs don't everyone—here's why Considering Starting on a GLP-1?

doi: 10.1093/eurheartj/ehz486, PMID: [DOI] [PubMed] [Google Scholar] 24

Most plans cover Ozempic for diabetes ($25-$100/month copay) but deny coverage for weight loss

Theyre also an opportunity to discuss any changes in hunger, cravings, or "food noise" those distracting thoughts about food that GLP-1 medications help suppress

Current NHS eligibility criteria for semaglutide 2.4 mg (Wegovy) for weight management, according to NICE TA875, include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea) For people from certain high-risk ethnic groups (such as South Asian, Chinese, Black African, or African-Caribbean), lower BMI thresholds apply (typically reduced by 2.5 kg/m) Treatment must be prescribed within specialist weight management services only Treatment is limited to a maximum duration of 2 years Must be used as an adjunct to a reduced-calorie diet and increased physical activity Liraglutide 3 mg (Saxenda) availability varies significantly across NHS regions and is not routinely commissioned in many areas

Compounding pharmacies typically prepare personalized medications by mixing, altering, or combining ingredients to meet specific needs prescribed by a doctor, under Section 503A

Wegovy received NICE approval in 2023 for weight management in adults with a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity